课题基金 / 基金详情

Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases

Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases
使用 TAL 效应核酸酶提高基因打靶的效率
批准号:
8456449
负责人:
Shengdar Tsai
金额:
$5.22万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2015-01-31

项目摘要

项目成果

Shengdar Tsai的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):这项提案的长期目标是开发广泛适用的方法,利用工程核酸酶促进人类体细胞和多能细胞中的基因靶向。其具体目标是:1)增强我们通过在人类体细胞和多能细胞中使用工程核酸酶(TAL效应核酸酶或TALEN)进行同源重组来对所有类型的遗传修饰进行基因工程的能力;以及2)提高我们使用TALEN衍生的缺口酶进行同源重组的能力。这项提案将利用一种高通量组装方法来创建工程化的TALEN,并将其应用于人类细胞系的基因工程。所提出的在人类基因组中引入小插入和单碱基修饰的方法的成功开发,将增强系统研究人类基因变异和功能之间关系的能力,并使以前仅限于小鼠模型系统的遗传操作成为可能。
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to develop broadly applicable methods to utilize engineered nucleases to facilitate gene targeting in human somatic and pluripotent cells. The specific aims are: 1) to enhance our ability to genetically engineer all types of genetic modifications by homologous recombination using engineered nucleases (TAL effector nucleases or TALENs) in human somatic and pluripotent cells and 2) to improve our ability to use TALEN-derived nicking enzymes for homologous recombination. This proposal will leverage a high-throughput assembly method for creating engineered TALENs and apply it to the genetic engineering of human cell lines. Successful development of the proposed methods for introducing small insertions and single-base modifications to the human genome will enhance the ability to systematically investigate the relationship between human gene variation and function and enable genetic manipulations that have been previously limited to mouse model systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
A novel human T-cell platform to define biological effects of genome editing
A novel human T-cell platform to define biological effects of genome editing
海外基金